Arch Venture Fund V Lp - Net Worth and Insider Trading
Arch Venture Fund V Lp Net Worth
The estimated net worth of Arch Venture Fund V Lp is at least $62 Million dollars as of 2024-11-10. Arch Venture Fund V Lp is the 10% Owner of Alnylam Pharmaceuticals Inc and owns about 222,500 shares of Alnylam Pharmaceuticals Inc (ALNY) stock worth over $62 Million. Details can be seen in Arch Venture Fund V Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Arch Venture Fund V Lp has not made any transactions after 2004-05-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Arch Venture Fund V Lp
Arch Venture Fund V Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Arch Venture Fund V Lp owns 4 companies in total, including Impinj Inc (PI) , NeurogesX Inc (NGSX) , and Cyclacel Pharmaceuticals Inc (CYCC) among others .
Click here to see the complete history of Arch Venture Fund V Lp’s form 4 insider trades.
Insider Ownership Summary of Arch Venture Fund V Lp
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
PI | Impinj Inc | 2016-07-20 | 10 percent owner |
NGSX | NeurogesX Inc | 2011-07-21 | 10 percent owner |
CYCC | Cyclacel Pharmaceuticals Inc | 2004-03-16 | 10 percent owner |
2004-05-27 | 10 percent owner |
Arch Venture Fund V Lp Latest Holdings Summary
Arch Venture Fund V Lp currently owns a total of 1 stock. Arch Venture Fund V Lp owns 222,500 shares of Alnylam Pharmaceuticals Inc (ALNY) as of May 27, 2004, with a value of $62 Million.
Latest Holdings of Arch Venture Fund V Lp
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ALNY | Alnylam Pharmaceuticals Inc | 2004-05-27 | 222,500 | 277.43 | 61,728,175 |
Holding Weightings of Arch Venture Fund V Lp
Arch Venture Fund V Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Arch Venture Fund V Lp has made a total of 0 transactions in Alnylam Pharmaceuticals Inc (ALNY) over the past 5 years. The most-recent trade in Alnylam Pharmaceuticals Inc is the sale of 0 shares on May 27, 2004, which brought Arch Venture Fund V Lp around $0.
Insider Trading History of Arch Venture Fund V Lp
- 1
Arch Venture Fund V Lp Trading Performance
Arch Venture Fund V Lp Ownership Network
Ownership Network List of Arch Venture Fund V Lp
Ownership Network Relation of Arch Venture Fund V Lp
Arch Venture Fund V Lp Owned Company Details
What does Impinj Inc do?
Who are the key executives at Impinj Inc?
Arch Venture Fund V Lp is the 10 percent owner of Impinj Inc. Other key executives at Impinj Inc include director & Chief Executive Officer Diorio Chris Ph.d. , Chief Financial Officer Cary Baker , and Chief Operating Officer Hussein Mecklai .
Impinj Inc (PI) Insider Trades Summary
Over the past 18 months, Arch Venture Fund V Lp made no insider transaction in Impinj Inc (PI). Other recent insider transactions involving Impinj Inc (PI) include a net sale of 203,464 shares made by Diorio Chris Ph.d. , a net sale of 77,435 shares made by Jeffrey Dossett , and a net sale of 64,309 shares made by Cary Baker .
In summary, during the past 3 months, insiders sold 832,037 shares of Impinj Inc (PI) in total and bought 4,264,393 shares, with a net purchase of 3,432,356 shares. During the past 18 months, 2,181,728 shares of Impinj Inc (PI) were sold and 5,740,087 shares were bought by its insiders, resulting in a net purchase of 3,558,359 shares.
Impinj Inc (PI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Impinj Inc Insider Transactions
Arch Venture Fund V Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Arch Venture Fund V Lp. You might contact Arch Venture Fund V Lp via mailing address: 8755 W. Higgins Road, Suite 1025, Chicago Il 60631.